Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-1474-2026

Remel, Inc recalls Campy CVA Medium 100/PK

Remel, IncLenexa, KS, United StatesReported Mar 4, 2026 · 4 months ago
Legal News Analyst ·

Reason for recall

Customer complaints report low to no recovery of Campylobacter Jejuni ATCC 33291 on identified lot of medium.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Affected products & lots

  • Campy CVA Medium 100/PKR01272
    UDI-DI 848838001055
    3 affected lots
    R012723391352026

What the firm is doing

On February 5, 2026, the firm notified affected customers via Urgent Medical Device Recall letter. Customers were instructed to review test results and destroy any remaining inventory of the affected lot.

DistributionShow details

US Nationwide distribution in the states of AZ, CO, IL, NJ, OH, TN, WA.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls